Bioactive peptides from egg: A review

Nutrition and Food Science

Volumn 45, Issue 2, 2015, Pages 190-212

  Bhat, Z F ^a   Kumar, Sunil ^a   Bhat, Hina Fayaz ^b  

^a SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF JAMMU   (India)

^b SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF KASHMIR   (India)

Author keywords

Bioactive peptides; Egg peptides; Future applications; Production

Indexed keywords

EID: 84924356901     PISSN: 00346659     EISSN: 17586917     Source Type: Journal    
DOI: 10.1108/NFS-10-2014-0088     Document Type: Article

References (163)

1. Abdallah, F. B. and Chahine, J. M. (1999), "Transferrins, the mechanism of iron release by ovotransferrin," European Journal of Biochemistry, Vol. 263 No. 3, pp. 912-920.
2. Abdou, A. M., Higashiguchi, S., Aboueleinin, A. M., Kim, M. and Ibrahim, H. R. (2007), "Antimicrobial peptides derived from hen egg lysozyme with inhibitory effect against Bacillus species," Food Control, Vol. 18 No. 2, pp. 173-178.
3. Abdou, A. M., Kim, M. and Sato, K. (2013), "Functional proteins and peptides of hen's egg origin," available at: http://dx. doi. org/10. 5772/54003.
4. Abdou, A. M., Kim, M. and Sato, K. (2013), "Functional proteins and peptides of hen's egg origin" in Hernandez-Ledesma, B. and Hsieh, C.-H. (Eds), Bioactive Food Peptides in Health and Disease, ISBN 978-953-51-0964-8, DOI: 10. 5772/54030.
5. Aguilera, O., Quiros, L. M. and Fierro, J. F. (2003), "Transferrins selectively cause ion efflux through bacterial and artificial membranes" FEBS Letter, Vol. 548 Nos 1/3, pp. 5-10.
6. Akai, S. and Alizadeh-Pasdar, N. (2006), "Rational designing of bioactive peptides," in Mine, V., Shahidi, F. and Taylor, F. (Eds), Nutraceutical Proteins and Peptides in Health and Disease, CRC Press, London, pp. 565-582.
7. Asakura, K., Kojima, T., Shirasaki, H. and Kataura, A. (1990), "Evaluation of the effects of antigen specific immunotherapy on chronic sinusitis in children with allergy" Auris Nasus Larynx, Vol. 17 No. 1, pp. 33-38.
8. Bah, C. S. F., Bekhit, A., El-Din, A., Carne, A. and McConnellc, M. A. (2013), "Slaughterhouse blood: an emerging source of bioactive compounds"Comprehensive Reviews in Food Science and Food Safety, Vol. 12 No. 3, pp. 314-331.
9. Baldauf, F., Belter, J., Horn, U., Krug, M., Metzlaff, M. and Polley, A. (1994), in Brantl, V. and Teschemacher, H. (Eds), α-Casomorphins and Related Peptides: Recent Developments, VCH Veinheim, pp. 73-80.
10. Banks, J. G., Board, R. G. and Sparks, N. H. C. (1986), "Natural antimicrobial systems and their potential in food preservation of the future" Biotechnology and Applied Biochemistry, Vol. 8 Nos 2/3, pp. 103-147.
11. Baron, F., Fauvel, S. and Gautier, M. (2000), "Behaviour of Salmonella enteritidis in industrial egg white: egg naturally contains factors inhibitory to salmonella growth," in Sim, J. S., Nakai, N. and Guenter, W. (Eds), Egg Nutrition and Biotechnology, CAB International, Oxon, Oxford, pp. 417-430.
12. Berrocal, R., Chanton, S., Juilleart, M. A., Pavillard, B., Scherz, J. C. and Jost, R. (1989), "Tryptic phosphopeptides from whole casein. II Physicochemical properties related to the solubilization of calcium," Journal of Dairy Research, Vol. 56 No. 3, pp. 335-341.
13. Brady, D., Gaines, S., Fenelon, L., McPartlin, J. and O'Farrelly, C. A. (2002), "A lipoproteinderived antimicrobial factor from hen-egg yolk is active against Streptococcus species" Journal of Food Science, Vol. 67 No. 8, pp. 3096-3103.
14. Brady, D., Lowe, N., Gaines, S., Fenelon, L., McPartlin, J. and O'Farrelly, C. (2003), "Inhibition of Streptococcus mutans growth by hen egg-derived fatty acids" Journal of Food and Science, Vol. 68 No. 4, pp. 1433-1437.
15. Brand, H. S., Lerner, U. H., Grubb, A., Beertsen, W. Nieuw Amerongen, A. V. and Everts, V. (2004), "Family 2 cystatins inhibit osteoclast-mediated bone resorption in calvarial bone explants" Bone, Vol. 35 No. 3, pp. 689-696.
16. Chakrabarti, S., Jahandideh, F. and Jianping, Wu. (2014), "Food-derived bioactive peptides on inflammation and oxidative stress" BioMed Research International, 2014, p. 608979, available at: http://dx. doi. org/10. 1155/2014/608979.
17. Chiang, W. E., Cordle, C. T. and Thomas, R. L. (1995), "Casein hydrolysate produced using a formed-in-place membrane reactor" Journal of Food and Science, Vol. 60 No. 6, pp. 1349-1352.
18. Choi, I., Jung, C., Choi, H., Kim, C. and Ha, H. (2005), "Effectiveness of phosvitin peptides on enhancing bioavailability of calcium and its accumulation in bones" Food Chemistry, Vol. 93 No. 4, pp. 577-583.
19. Choi, I., Jung, C., Seog, H. and Choi, H. (2004), "Purification of phosvitin from egg yolk and determination of its physicochemical properties" Food Science and Biotechnology, Vol. 13 No. 4, pp. 434-437.
20. Das, S., Banerjee, S. and Gupta, J. D. (1992), "Experimental evaluation of preventative and therapeutic potential of lysozyme" Chemotherapy, Vol. 38 No. 5, pp. 350-357.
21. Davalos, A., Miguel, M., Bartolome, B. and Lopez-Fandino, R. (2004), "Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis" Journal of Food Protection, Vol. 67 No. 9, pp. 1939-1944.
22. Dave, L. A., Montoya, C. A., Rutherfurd, S. M. and Moughan, P. J. (2014), "Gastrointestinal endogenous proteins as a source of bioactive peptides-an in silico study" PLoS ONE, Vol. 9 No. 6, pp. e98922.
23. deCosta, E. L., Rocha Montijo, J. A. and Netto, F. M. (2007), "Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates" International Dairy Journal, Vol. 17 No. 6, pp. 632-640.
24. Diplock, A. T., Aggett, P. J., Ashwell, M., Bornet, F., Fern, E. B. and Roberfroid, M. B. (2000), "Scientific concepts of functional foods in Europe: consensus document," in Buttriss, J. and Saltmarsh, M. (Eds), Functional Foods II-Claims and Evidence, The Royal Society of Chemistry, Cambridge, pp. 8-59.
25. Donkor, O., Henriksson, A., Vasiljevic, T. and Shah, N. P. (2007), "Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk," Le Lait, Vol. 87 No. 1, pp. 21-38.
26. Dziuba, B. and Dziuba, M. (2014), "Milk proteins-derived bioactive peptides in dairy products: molecular, biological and methodological aspects," ACTA Scientiarum Polonorum Technologia Alimentaria, Vol. 13 No. 1, pp. 5-25.
27. Dziuba, J. and Iwaniak, A. (2006), "Database of protein and bioactive peptide sequences," in Mine, V. and Shahidi, F. (Eds), Nutraceutical Proteins and Peptides in Health and Disease, Taylor and Francis, London, pp. 543-563.
28. Ebina, T. and Tsukada, K. (1991), "Protease inhibitors prevent the development of human rotavirus-induced diarrhea in suckling mice" Microbiology Immunology, Vol. 35 No. 7, pp. 583-588.
29. Eckert, E., Zambrowicz, A., Pokora, M., Polanowski, A., Chrzanowska, J., Szoltysik, M., Dąbrowska, A., Różánski, H. and Trziszka, T. (2013), "Biologically active peptides derived from egg proteins" World's Poultry Science Journal, Vol. 69 No. 2, pp. 375-386.
30. Erdmann, K., Cheung, B. W. Y. and Schröder, H. (2008), "The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease"The Journal of Nutritional Biochemistry, Vol. 19 No. 10, pp. 643-654.
31. Fan, X., Subramaniam, R., Weissm, M. F. and Monnier, V. M. (2003), "Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264. 7 cells through activation of mitogenactivating protein kinase, nuclear factor kappaB and intracellular reactive oxygen species formation" Archives of Biochemistry and Biophysics, Vol. 409 No. 2, pp. 274-286.
32. FitzGerald, R. and Murray, B. A. (2006), "Bioactive peptides and lactic fermentations" International Journal of Dairy Technology, Vol. 59 No. 2, pp. 118-125.
33. FitzGerald, R. J. and Meisel, H. (2003), "Milk protein hydrolysates and bioactive peptides" in Fox, P. F. and McSweeney, P. L. H. (Eds), Advanced Dairy Chemistry, 3rd ed., Proteins Vol. 1, Kluwer Academic/Plenum Publishers, New York, NY, pp. 675-698.
34. FitzGerald, R. J., Murray, B. A. and Walsh, D. J. (2004), "Hypotensive peptides from milk proteins" Journal of Nutrition, Vol. 134 No. 4, pp. 980S-988S.
35. Fuglsang, A., Rattray, F. P., Nilsson, D. and Nyborg, N. C. B. (2003), "Lactic acid bacteria: Inhibition of angiotensin converting enzyme in vitro and in vivo" Antonie van Leeuwenhoek, Vol. 83 No. 1, pp. 27-34.
36. Fujita, H., Sasaki, R. and Yoshikawa, M. (1995b), "Potentiation of the antihypertensive activity of orally administered Ovokinin, a vasorelaxing peptide derived from ovalbumin, by emulsification in egg phosphatidyl-choline" Bioscience, Biotechnology, and Biochemistry, Vol. 59 No. 12, pp. 2344-2345.
37. Fujita, H., Usui, H., Kurahashi, K. and Yoshikawa, M. (1995a), "Isolation and characterization of ovokinin, a bradykinin B1 agonist peptide derived from ovalbumin" Peptides, Vol. 16 No. 5, pp. 785-790.
38. Fujita, H., Yokoyama, K. and Yoshikawa, M. (2000), "Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins," Journal of Food Science, Vol. 65 No. 4, pp. 564-569.
39. Gauthier, S. F., Pouliot, Y. and Saint-Sauveur, D. (2006), "Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins," International Dairy Journal, Vol. 16 No. 11, pp. 1315-1323.
40. Giansanti, F., Rossi, P., Massucci, M. T., Botti, D., Antonini, G., Valenti, P. and Seganti, L. (2002), "Antiviral activity of ovotransferrin discloses an evolutionary strategy for the defensive activities of lactoferrin," Biochemistry and Cell Biology, Vol. 80 No. 1, pp. 125-130.
41. Gibbs, B. F., Zougman, A., Masse, R. and Mulligan, C. (2004), "Production and characterization of bioactive peptides from soy hydrolysate and soy-fermented food" Food Research International, Vol. 37 No. 2, pp. 123-131.
42. Gill, I., López-Fandino, R., Jorba, X. and Vulfson, E. N. (1996), "Biologically active peptides and enzymatic approaches to their production," Enzyme Microbial Technology, Vol. 18 No. 3, pp. 162-183.
43. Gobbetti, M., Minervini, F. and Rizzello, C. G. (2004), "Angiotensin Iconverting-enzyme-inhibitory and antimicrobial bioactive peptides," International Journal of Dairy Technology, Vol. 57 Nos 2/3, pp. 172-188.
44. Gobbetti, M., Minervini, F. and Rizzello, C. G. (2007), "Bioactive peptides in dairy products," in Hui, Y. H. (Ed.), Handbook of Food Products Manufacturing, John Wiley and Sons, Inc., Hoboken, NJ, pp. 489-517.
45. Goldberg, J., Shrikant, P. and Mescher, M. F. (2003), "In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen)," Journal of Immunology, Vol. 170 No. 1, pp. 228-235.
46. Gomez-Ruiz, J. A., Ramos, M. and Recio, I. (2002), "Angiotensin-converting-enzyme-inhibitory peptides in Manchengo cheeses manifactured with different starter cultures," International Dairy Journal, Vol. 12 No. 8, pp. 697-706.
47. Hartmann, R. and Meisel, H. (2007), "Food-derived peptides with biological activity: from research to food applications," Current Opinion in Biotechnology, Vol. 18 No. 2, pp. 163-169.
48. Hatta, H., Tsuda, K., Ozeki, M., Kim, M., Yamamoto, T., Otake, S., Horosawa, M., Katz, J., Childers, N. K. and Michalek, S. M. (1997), "Passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans," Caries Research, Vol. 31 No. 4, pp. 268-274.
49. He, X., Tsang, T. C., Luo, P., Zhang, T. and Harris, D. T. (2003), "Enhanced tumor immunogenicity through coupling cytokine expression with antigen presentation," Cancer Gene Therapy, Vol. 10 No. 9, pp. 669-677.
50. Holen, E., Bolann, B. and Elsayed, S. (2001), "Novel B and T cell epitopes of chicken ovomucoid (Gald 1) induce T cell secretion of IL-6, IL-13, and IFN-gamma" Journal of Clinical and Experimental Allergy, Vol. 31, pp. 952-964.
51. Hughey, V. L., Wilger, P. A. and Johnson, E. A. (1989), "Antibacterial activity of hen white lysozyme against Listeria monocytogens Scott A in foods" Applied and Environmental Microbiology, Vol. 55 No. 3, pp. 631-638.
52. Ibrahim, H. R., Aoki, T. and Pellegrini, A. (2002), "Strategies for new antimicrobial proteins and peptides: lysozyme and aprotinin as model molecules" Current Pharmaceutical Design, Vol. 8 No. 9, pp. 671-693.
53. Ibrahim, H. R., Sugimoto, Y. and Aoki, T. (2000), "Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism" Biochimica et Biophysica Acta, Vol. 1523 Nos 2/3, pp. 196-205.
54. Ibrahim, H. R., Thomas, U. and Pellegrini, A. (2001), "A helix-loop peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action" The Journal of Biological Chemistry, Vol. 276 No. 47, pp. 43767-43774.
55. Ishikawa, S., Yano, Y., Arihara, K. and Itoh, M. (2004), "Egg yolk phosvitin inhibits hydroxyl radical formation from the Fenton reaction" Bioscience, Biotechnology, and Biochemistry, Vol. 68 No. 6, pp. 1324-1331.
56. Jiang, B. and Mine, Y. (2000), "Preparation of novel functional oligophosphopeptides from hen egg yolk phosvitin" Journal of Agricultural and Food Chemistry, Vol. 48 No. 4, pp. 990-994.
57. Jiang, B. and Mine, Y. (2001), "Phosphopeptides derived from hen egg yolk phosvitin: effect of molecular size on the calcium-binding properties" Bioscience, Biotechnology, and Biochemistry, Vol. 65 No. 5, pp. 1187-1190.
58. Kassaify, Z. G. and Mine, Y. (2004a), "Non-immunized egg yolk powder can suppress the colonization of Salmonella typhimurium, E coli 0157: H7 and Campylobacter jejuni in laying hens" Poultry Science, Vol. 83 No. 9, pp. 1497-1506.
59. Kassaify, Z. G. and Mine, Y. (2004b), "Effect of food protein supplements on Salmonella enteritidis infection and prevention in laying hens" Poultry Science, Vol. 83 No. 5, pp. 753-760.
60. Kassaify, Z. G., Li, E. W. Y. and Mine, Y. (2005), "Identification of antiadhesive fractions in nonimmunized egg yolk powder: In vitro study," Journal of Agricultural and Food Chemistry, Vol. 53 No. 11, pp. 4607-4614.
61. Kato, T., Imatani, T., Miura, T., Minaguchi, K., Saitoh, E. and Okuda, K. (2000), "Cytokine-inducing activity of family 2 cystatins" Biological Chemistry, Vol. 381 No. 11, pp. 1143-1147.
62. Kitts, D. D. and Weiler, K. (2003), "Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery" Current Pharmaceutical Design, Vol. 9 No. 16, pp. 1309-1323.
63. Kobayashi, K., Hattori, M., Hara-Kudo, Y., Okubo, T., Yamamoto, S., Takita, T. and Sugita-Konishi, Y. (2004), "Glycopeptide derived from hen egg ovomucin has the ability to bind enterohemorrhagic Escherichia coli O157: H7" Journal of Agricultural and Food Chemistry, Vol. 52 No. 18, pp. 5740-5746.
64. Korhonen, H. (2002), "Technology options for new nutritional concepts" International Journal of Dairy Technology, Vol. 55 No. 2, pp. 79-88.
65. Korhonen, H. (2009), "Milk-derived bioactive peptides: from science to applications" Journal of Functional Foods, Vol. 1 No. 2, pp. 177-187.
66. Korhonen, H. and Pihlanto, A. (2003), "Food-derived bioactive peptides-opportunities for designing future foods" Current Pharmaceutical Design, Vol. 9, pp. 1297-1308.
67. Korhonen, H. and Pihlanto, A. (2007), "Technological options for the production of health-promoting proteins and peptides derived from milk and colostrums" Current Pharmaceutical Design, Vol. 13 No. 8, pp. 829-843.
68. Korpela, J., Salonen, E. M., Kuusela, P., Sarvas, M. and Vaheri, A. (1984), "Binding of avidin to bacteria and to the outer membrane porin of Escherichia coli" FEMS Microbiology Letters, Vol. 22 No. 1, pp. 3-10.
69. Kovacs-Nolan, J. and Mine, Y. (2004), "Avian egg antibodies: Basic and potential applications" Avian and Poultry Biology Reviews, Vol. 15 No. 1, pp. 25-46.
70. Kovacs-Nolan, J., Phillips, M. and Mine, Y. (2005), "Advances in the value of eggs and egg components for human health"Journal of Agricultural and Food Chemistry, Vol. 53 No. 22, pp. 8421-8431.
71. Kruger, C., Pearson, S. K., Kodama, Y., Vacca Simith, A., Bowen, W. H. and Hammarstron, L. (2004), "The effects of egg-derived antibodies to glucotransferases on dental caries in rats" Caries Research, Vol. 38 No. 1, pp. 9-14.
72. Lee-Huang, S., Huang, P. L., Sun, Y., Huang, P. L., Kumg, H. F., Bithe, D. L. and Chen, H. C. (1999), "Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin" Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, pp. 2678-2681.
73. Leem, K. H., Kim, M. G., Kim, H. K., Oi, Y. and Kim, M. (2004a), "Effect of egg yolk proteins on the longitudinal bone growth in rat," Proceeding of 16th Annual meeting Japanese Society of Bioscience Biotechnology and Agrochemistry (in Japanese), Hiroshima, p. 200.
74. Leem, K. H., Kim, M. G., Kim, H. M., Kim, M., Lee, Y. J. and Kim, H. K. (2004b), "Effect of egg yolk proteins on the longitudinal bone growth of adolescent male rat," Bioscience Biotechnology and Biochemistry, Vol. 68, p. 2388.
75. Li-Chan, E. C. Y., Powrie, W. D. and Nakai, S. (1995), "The chemistry of eggs and egg products," in Stadelman, W. J. and Cotterill, O. J. (Ed.), Egg Science and Technology, 4th ed., Haworth Press, New York, NY, pp. 105-175.
76. Liu, J. B., Yu, Z. P., Zhao, W. Z., Lin, S. Y., Wang, E. L., Zhang, Y., Hao, Y., Wang, Z. Z. and Chen, F. (2010), "Isolation and identification of angiotensin-converting enzyme inhibitory peptides from egg-white protein hydrolysates," Food Chemistry, Vol. 122, pp. 1159-1163.
77. Lopez-Exposito, I., Quiros, A., Amigo, L. and Recio, I. (2007), "Casein hydrolysates as a source of antimicrobial, antioxydant and antihypertensive peptides," Lait, Vol. 87, pp. 241-249.
78. Lopez-Expo sito, I. and Recio, I. (2006), "Antibacterial activity of peptides and folding variants from milk proteins," International Dairy Journal, Vol. 16 No. 11, pp. 1294-1305.
79. Losso, J. N., Nakai, S. and Charter, E. A. (2000), "Lysozyme," in Naidu, A. S. (Ed.), Natural Food Antimicrobial Systems, CRC Press, New York, NY, pp. 185-210.
80. Lu, C. H-L. and Baker, R. C. (1986), "Characteristics of egg-yolk phosvitin as an antioxidant for inhibiting metal-catalyzed phospholipid oxidations" Poultry Science, Vol. 65 No. 11, pp. 2065-2070.
81. McConnell, M. A., Buchan, G., Borissenko, M. V. and Brooks, H. J. L. (2001), "A comparison of IgG and IgG1 activity in an early milk concentrate from non-immunised cows and a milk from hyperimmunised animals," Food Research International, Vol. 34 Nos 2/3, pp. 255-261.
82. McDonagh, D. and FitzGerald, R. J. (1998), "Production of caseinophosphopeptides (CPPs) from sodium caseinate using a range of commercial protease preparations," International Dairy Journal, Vol. 8 No. 1, pp. 39-45.
83. Maeno, M., Yamamoto, N. and Takano, T. (1996), "Identification of antihypertensive peptides from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790," Journal of Dairy Science, Vol. 73, pp. 1316-1321.
84. Mannheim, A. and Cheryan, M. (1990), "Continuous hydrolysis of milk protein in a membrane reactor," Journal of Food Science, Vol. 55, pp. 381-385.
85. Martin-Orue, C., Henry, G. and Bouhallab, S. (1999), "Tryptic hydrolysis of k-caseinomacropeptide: control of the enzymatic reaction in a continuous membrane reactor," Enzyme and Microbiol Technology, Vol. 24, pp. 173-180.
86. Maruo, K., Akaike, T., Ono, T. and Maeda, H. (1998), "Involvement of bradykinin generation in intravascular dissemination of Vibrio Vulnificus and prevention of invasion by a bradykinin antagonist," Infection and Immunity, Vol. 66, pp. 866-869.
87. Maruyama, S. and Suzuki, H. (1982), "A peptide inhibitor of angiotensin I-converting enzyme in the tryptic hydrolysate of casein," Agricultaural and Biological Chemistry, Vol. 46, pp. 1393-1394.
88. Matar, C., LeBlanc, J. G., Martin, L. and Perdigo, N. G. (2003), "Biologically active peptides released in fermented milk: Role and functions," in Farnworth, E. R. (Ed.), Handbook of Fermented Functional Foods, Functional Foods and Nutraceuticals Series, CRC Press, FL, pp. 177-201.
89. Matoba, N., Usui, H., Fujita, H. and Yoshikawa, M. (1999), "A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery," FEBS Letters, Vol. 452, pp. 181-184.
90. Matoba, N., Yamada, Y., Usui, H., Nakagiri, R. and Yoshikawa, M. (2001), "Designing potent derivatives of ovokinin (2-7), an anti-hypertensive peptide derived from ovalbumin," Bioscience, Biotechnology, and Biochemistry, Vol. 65 No. 3, pp. 736-739.
91. Meisel, H. and FitzGerald, R. J. (2003), "Biofunctional peptides from milk proteins: Mineral binding and cytomodulatory effects," Current Pharmaceutical Design, Vol. 9 No. 16, pp. 1289-1295.
92. Meisel, H., Walsh, D. J., Murray, B. and FitzGerald, R. J. (2006), "ACE inhibitory peptides," in Mine, Y. and Shahidi, F. (Eds), Nutraceutical Proteins and Peptides in Health and Disease, Nutraceutical Science and Technology, Vol. 4, Taylor and Francis, Boca Raton, FL, pp. 269-315.
93. Meister, W., Birch-Hirschfeld, E., Koban, M., Schilken, U., Kunze, G. and Blasig, R. (1994), "Recent developments," in Brantl, V. and Teschemacher, H. (Eds), α-casomorphins and Related Peptides, VCH Veinheim, pp. 66-72.
94. Miguel, M., Alvarez, Y., Lopez-Fandino, R., Alonso, M. and Salaices, M. (2007), "Vasodilator effects of peptides derived from egg white proteins," Regulatory Peptides, Vol. 140 No. 3, pp. 131-135.
95. Miguel, M., Lopez-Fandino, R., Ramos, M. and Aleixandre, A. (2005), "Short-term effect of egg white hydrolysate products on the arterial blood pressure of hypertensive rats," British Journal of Nutrition, Vol. 94 No. 5, pp. 731-737.
96. Miguel, M., Ramos, M., Aleixandre, M. A. and López-Fandio, R. (2006), "Antihypertensive peptides obtained from egg white proteins by enzymatic hydrolysis, stability under simulated gastrointestinal digestion," Journal of Agricultural and Food Chemistry, Vol. 54 No. 6, pp. 726-731.
97. Miguel, M., Recio, I., Gómez-Ruiz, J. A., Ramos, M. and López-Fandio, R. (2004), "Angiotensin I-converting enzyme inhibitory activity of peptides derived from egg white proteins by enzymatic hydrolysis," The Journal of Food Protection, Vol. 67 No. 9, pp. 1914-1920.
98. Mils, S., Ross, R. P., Hill, C., Fitzgerald, G. F. and Stanton, C. (2011), "Milk intelligence: mining milk for bioactive substances associated with human heath," International Dairy Journal, Vol. 21 No. 6, pp. 377-401.
99. Mine, Y. and Kovacs-Nolan, J. (2005), "New insights in biologically active proteins and peptides derived from hen egg," paper presented in XIth European Symposium, Quality of Eggs and Egg Products, Doorwerth, 23-26 May.
100. Mine, Y., Ma, F. and Lauriau, S. (2004), "Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme," Journal of Agricultural and Food Chemistry, Vol. 52 No. 5, pp. 1088-1094.
101. Nakamura, S., Ogawa, M., Nakai, S., Kato, A. and Kitts, D. D. (1998), "Antioxidant activity of a maillard-type phosvitin-galactomannan conjugate with emulsifying properties and heat stability," Journal of Agricultural and Food Chemistry, Vol. 46 No. 10, pp. 3958-3963.
102. Narai-Kanayama, A., Shikata, Y., Hosono, M. and Aso, K. (2010), "High level production of bioactive di-and tri-tyrosine peptides by protease-catalysed reactions," Journal of Biotechnology, Vol. 150 No. 3, pp. 343-347.
103. Oguro, T., Ohaki, Y., Asano, G., Ebina, T. and Watanabe, K. (2001), "Ultrastructural and immunohistochemical characterization on the effect of ovomucin in tumor angiogenesis," Jap. J. Clin. Elect. Micro., Vol. 33 No. 2, pp. 89-99.
104. Oi, Y., Ji, M. Y., Leem, K. H., Cho, S. W. and Kim, M. (2005), "The effect of hen egg yolk peptide on bone growth," 17th Annual meeting Japanese Society of Bioscience Biotechnology and Agrochemistry, Hokkaido.
105. Pacor, S., Gagliard, R., Di Daniel, E., Vadori, M. and Sava, G. (1999), "In vitro down regulation of ICAM-1 and E-cadherin and in vitro reduction of lung metastases of TS/A adenocarcinoma by a lysozyme derivative," International Journal of Molecular Medicine, Vol. 4 No. 7, pp. 369-375.
106. Park, P. J., Jung, W. K., Nam, K. S., Shahidi, F. and Kim, S. K. (2001), "Purification and characterization of antioxidative peptides from protein hydrolysate of lecithin-free egg yolk," Journal of American Oil Chemist Society, Vol. 78 No. 6, pp. 651-656.
107. Pellegrini, A., Hulsmeier, A., Hunziker, P. and Thomas, U. (2004), "Proteolytic fragments of ovalbumin display antimicrobial activity," Biochimica et Biophysica Acta, Vol. 1672 No. 2, pp. 76-85.
108. Pellegrini, A., Thomas, U., Bramaz, N., Klauser, S., Hunziker, P. and Von Fellenberg, R. (1997), "Identification and isolation of bactericidal domain in chicken egg white lysozyme," Journal of Applied Microbiology, Vol. 82 No. 3, pp. 372-378.
109. Pellegrini, A., Thomas, U., Wild, P., Schraner, E. and Von Fellenberg, R. (2000), "Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane permeability of Escherichia coli," Research in Microbiology, Vol. 155 No. 2, pp. 69-77.
110. Perea, A. and Ugalde, U. (1996), "Continuous hydrolysis of whey proteins in a membrane recycle reactor," Enzyme and Microbial Technology, Vol. 18 No. 1, pp. 29-34.
111. Pihlanto, A. (2006), "Antioxidative peptides derived from milk proteins," International Dairy Journal, Vol. 16 No. 11, pp. 1306-1314.
112. Pihlanto-Leppälä, A., Koskinen, P., Piilola, K., Tupasela, T. and Korhonen, H. (2000), "Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides," Journal of Dairy Research, Vol. 67 No. 1, pp. 53-64.
113. Pouliot, Y., Gauthier, S. F. and Groleau, P. E. (2006), "Membrane-based fractionation and purification strategies for bioactive peptides," in Mine, Y. and Shahidi, F. (Ed.), Nutraceutical proteins and Peptides in Health and Disease Nutraceutical Science and Technology, Vol. 4, Taylor and Francis, Boca Raton, FL, pp. 639-658.
114. Prak, K., Maruyama, Y., Maruyama, N. and Utsumi, S. (2006), "Design of genetically modified soybean proglycinin A1aB1b with multiple copies of bioactive peptide sequences," Peptides, Vol. 27 No. 6, pp. 1179-1186.
115. Proctor, V. A. and Cunningham, F. E. (1988), "The chemistry of lysozyme and its use as a food preservative and as pharmaceutical," Critical Reviews in Food Science and Nutrition, Vol. 26 No. 4, pp. 359-395.
116. Reynolds, E. C., Cai, F., Shen, P. and Walker, G. D. (2003), "Retention in plaque and remineralisation of enamel lesions by various forms of calcium in a mouth rinse or sugar-free chewing gum," Journal of Dental Research, Vol. 82 No. 3, pp. 206-211.
117. Roufik, S., Gauthier, S. F. and Turgeon, S. L. (2006), "In vitro digestibility of bioactive peptides derived from bovine α-lactoglobulin," International Dairy Journal, Vol. 16 No. 4, pp. 294-302.
118. Ruan, C. Q., Chi, Y. J. and Zhang, R. D. (2010), "Kinetics of hydrolysis of egg white protein by pepsin," Czech Journal of Food Sciences, Vol. 28, pp. 355-363.
119. Saiga, A., Okumura, T., Makihara, T., Katsuta, S., Shimizu, T. and Yamada, R. (2003), "Angiotensin I-converting enzymes inhibitory peptides in a hydrolyzed chicken breast muscle extract," Journal of Agricultural and Food Chemistry, Vol. 51 No. 6, pp. 1740-1745.
120. Sakanaka, S. and Tachibana, Y. (2006), "Active oxygen scavenging activity of egg-yolk protein hydrolysates and their effects on lipid oxidation in beef and tuna homogenates," Food Chemistry, Vol. 95, pp. 243-249.
121. Saleh, Y., Siewinski, M., Kielan, W., Ziolkowski, P., Grybos, M. and Rybka, J. (2003), "Regulation of cathepsin B and L expression in vitro in gastric cancer tissues by egg cystatin," Journal of Experimental Therapeutics and Oncology, Vol. 3 No. 6, pp. 319-324.
122. Sattar Khan, M. A., Nakamura, S., Ogawa, M., Akita, E., Azakami, H. and Kato, A. (2000), "Bactericidal action of egg yolk phosvitin against Escherichia coli under thermal stress," Journal of Agricultural and Food Chemistry, Vol. 48 No. 5, pp. 1503-1506.
123. Sava, G. (1996), "Pharmacological aspects and therapeutic applications of lysozymes," Experimental Science, Vol. 75, pp. 433-449.
124. Sava, G., Ceschia, V., Pacor, S. and Zabucchi, G. (1991), "Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma," Anticancer Research, Vol. 11 No. 3, pp. 1109-1113.
125. Sava, G., Pacor, S., Dasic, G. and Bergamo, A. (1995), "Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas," Anticancer Research, Vol. 15 No. 5, pp. 1883-1888.
126. Scruggs, P., Filipeanu, C. M., Yang, J., Kang Chang, J. and Dun, N. J. (2004), "Interaction of ovokinin (2-7) with vascular bradykinin 2 receptors," Regulatory Peptides, Vol. 120 Nos 1/3, pp. 85-91.
127. Sharon, N. and Ofek, I. (2002), "Fighting infectious diseases with inhibitors of microbial adhesion to host tissues," Critical Reviews in Food Science and Nutrition, Vol. 42 No. 3, pp. 267-272.
128. Shcherbakova, E. G., Bukhman, V. M., Isakova, E. B., Bodiagin, D. A., Arkhipova, N. A., Rastunova, G. A., Vorob'eva, L. S. and Lipatov, N. N. (2002), "Effect of lysozyme on the growth of murine lymphoma and antineoplastic activity of cyclophosphamide," Antibiotic Khimioter, Vol. 47 No. 11, pp. 3-8.
129. Shen, P., Cai, F., Nowicki, A., Vincent, J. and Reynolds, E. C. (2001), "Remineralization of enamel subsurface lesions by sugar-free chewing gum containing casein phosphopeptideamorphous calcium phosphate," Journal of Dental Research, Vol. 80 No. 12, pp. 2066-2070.
130. Silva, S. V. and Malcata, F. X. (2005), "Caseins as source of bioactive peptides," International Dairy Journal, Vol. 15, pp. 1-15.
131. Singh, B. P., Vij, S. and Hati, S. (2014), "Functional significance of bioactive peptides derived from soybean," Peptides, Vol. 54, pp. 171-179.
132. Smith, D. J., King, W. F. and Godiska, R. (2001), "Passive transfer of Immunoglobulin Y antibody to Streptococcus mutans glucan binding protein B can confer protection against experimental dental caries," Infection and Immunity, Vol. 5 No. 5, pp. 3135-3142.
133. Stuknyte, M., De Noni, I., Gugliemetti, S., Minuzzo, M. and Mora, D. (2011), "Potential immunomodulatory activity of bovine casein hydrolysates produced after digestion with proteinase of lactic acid bacteria," International Dairy Journal, Vol. 21 No. 10, pp. 763-769.
134. Suarez-Jimenez, G.-M., Burgos-Hernandez, A. and Ezquerra-Brauer, J. M. (2012), "Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals," Marine Drugs, Vol. 10 No. 5, pp. 963-986.
135. Sugahara, T., Murakami, F., Yamada, Y. and Sasaki, T. (2000), "The mode of actions of lysozyme as an immunoglobulin production stimulating factor," Biochimica et Biophysica Acta, Vol. 1475 No. 1, pp. 27-34.
136. Sun-Jong, Y., Chibuike, C., Udenigwe, R., Aluko, E. and Jianping, W. (2010), "Multifunctional peptides from egg white lysozyme," Food Res. Int., Vol. 43, pp. 848-855.
137. Tanizaki, H., Tanaka, H., Iwata, H. and Kato, A. (1997), "Activation of macrophages by sulfated glycopeptides in ovomucin, yolk membrane, and chalazae in chicken eggs," Bioscience, Biotechnology, and Biochemistry, Vol. 61 No. 11, pp. 1883-1889.
138. Tenuovo, J. (2002), "Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety," Oral Diseases, Vol. 8 No. 1, pp. 23-29.
139. Teschemacher, H. (2003), "Opioid receptor ligands derived from food proteins," Current Pharmaceutical Design, Vol. 9 No. 16, pp. 1331-1344.
140. Tezuka, H. and Yoshikawa, M. (1995), Paper presented at the Annual Meeting of the Japan Society for Bioscience Biotechnology and Agro-chemistry, Tokyo, p. 163.
141. Tsuge, Y., Shimoyamada, M. and Watanabe, K. (1996a), "Binding of egg white proteins to viruses," Bioscience, Biotechnology, and Biochemistry, Vol. 60 No. 9, pp. 1503-1504.
142. Tsuge, Y., Shimoyamada, M. and Watanabe, K. (1996b), "Differences in hemagglutination inhibition activity against bovine rotavirus and hen Newcastle disease virus based on the subunits in hen egg white ovomucin," Bioscience, Biotechnology, and Biochemistry, Vol. 60 No. 9, pp. 1505-1506.
143. Tsuge, Y., Shimoyamada, M. and Watanabe, K. (1997a), "Structural features of Newcastle disease virus-and anti-ovomucin antibody-binding glycopeptides from pronase-treated ovomucin," Journal of Agricultural and Food Chemistry, Vol. 45 No. 7, pp. 2393-2398.
144. Tsuge, Y., Shimoyamada, M. and Watanabe, K. (1997b), "Bindings of ovomuc into Newcastle disease virus and anti-ovomucin antibodies and its heat stability based on binding abilities," Journal of Agricultural and Food Chemistry, Vol. 45 No. 12, pp. 4529-4634.
145. Urista, M. C., Fernández, Á. R., Rodriguez, F. R., Cuenca, A. A. and Jurado, T. A. (2011), "Review: production and functionality of active peptides from milk," Food Science & Technology, Vol. 17 No. 4, pp. 293-317.
146. Vermeirssen, V., van Camp, J. and Verstraete, W. (2004), "Bioavailability of angiotensin I-converting enzyme inhibitory peptides," British Journal of Nutrition, Vol. 92 No. 3, pp. 357-366.
147. Vidovic, D., Graddis, T., Chen, F., Slagle, P., Diegel, M. and Stepan Laus, R. (2002), "Antitumor vaccination with HER-2-derived recombinant antigens," International Journal of Cancer, Vol. 102, pp. 660-664.
148. Watanabe, K., Tsuge, Y., Shimoyamada, M., Ogama, N. and Ebina, T. (1998), "Antitumor effects of pronase treated fragments, glycopeptides, from ovomucin in hen egg white in a double grafted tumor system," Journal of Agricultural and Food Chemistry, Vol. 46 No. 8, p. 3033.
149. Xie, H., Huff, G. R., Huff, W. E., Balog, J. M. and Rath, N. C. (2002), "Effects of ovotransferrin on chicken macrophages and heterophil-granulocytes," Developmental and Comparative Immunology, Vol. 26 No. 9, pp. 805-815.
150. Xu, X., Katayama, S. and Mine, Y. (2007), "Antioxidant activity of tryptic digests of hen egg yolk phosvitin," Journal of Agricultural and Food Chemistry, Vol. 87 No. 14, pp. 2604-2608.
151. Yamamoto, N., Akino, A. and Takano, T. (1994), "Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790," Journal of Dairy Science, Vol. 77 No. 4, pp. 917-922.
152. Yamamoto, N., Ejiri, M. and Mizuno, S. (2003), "Biogenic peptides and their potential use," Current Pharmaceutical Design, Vol. 9 No. 16, pp. 1345-1355.
153. Yamamoto, Y., Sogo, N., Iwao, R. and Miyamoto, T. (1990), "Antioxidant effect of egg yolk on linoleate in emulsions," Agricultural and Biological Chemistry, Vol. 54 No. 12, pp. 30-99.
154. Ying, Li. and Jianmei, Yu. (2014), "Research progress in structure-activity relationship of bioactive peptides," Journal of Medicinal Food, Vol. 18 No. 2, pp. 147-156.
155. Yoshii, H., Tachi, N., Ohba, R., Sakamura, O., Takeyama, H. and Itani, T. (2001), "Antihypertensive effect of ACE inhibitory oligopeptides from chicken egg yolks," Comparative Biochemistry and Physiology, Vol. 128 No. 1, pp. 27-33.
156. Young, D., Fan, M. Z. and Mine, Y. (2010), "Egg yolk peptides up-regulate glutathione synthesis and antioxidant enzyme activities in a porcine model of intestinal oxidative stress," Journal of Agricultural and Food Chemistry, Vol. 58 No. 13, pp. 7624-7633.
157. Young, D., Nau, F., Pasco, M. and Mine, Y. (2011), "Identification of hen egg yolk-derived phosvitin phosphopeptides and their effects on gene expression profiling against oxidative stress induced Caco-2 cells," Journal of Agricultural and Food Chemistry, Vol. 59 No. 17, pp. 9207-9218.
158. Yu, Z., Yin, Y., Zhao, W., Chen, F. and Liu, J. (2014), "Application and bioactive properties of proteins and peptides derived from hen eggs: opportunities and challenges," Journal of the Science of Food and Agriculture, Vol. 94 No. 14, pp. 2839-2845.
159. Zambrowicz, A., Timmer, M., Eckert, E. and Trziszka, T. (2013), "Evaluation of the ACE-inhibitory activity of egg-white proteins degraded with pepsin," Polish Journal in Food and Nutrition, Vol. 63 No. 2, pp. 103-108.
160. Zhipeng, Y., Wenzhu, Z., Jingbo, L., Jing, L. and Feng, C. (2011), "QIGLF, a novel angiotensin I-converting enzyme-inhibitory peptide from egg white protein," Journal of the Science of Food and Agriculture, Vol. 91 No. 5, pp. 921-926.
161. Chang-Qing, R., Yu-Jie, C. and Rui-Dong, Z. (2010), "Kinetics of hydrolysis of egg white protein by pepsin," Czech Journal of Food Science, Vol. 28 No. 5, pp. 355-363.
162. Fujita, H., Yamagami, T. and Ohshima, K. (2001), "Effects of an ACE-inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects," Nutrition Research, Vol. 21 No. 8, pp. 1149-1158.
163. You, S.-J., Udenigwe, C. C., Aluko, R. E. and Wua, J. (2010), "Multifunctional peptides from egg white lysozyme," Food Research International, Vol. 43 No. 3, pp. 848-855.